Skip to main content

What are national networks?

Published on 29 March 2022

Cancer networks

National cancer managed clinical networks (MCNs) were established as a means of delivering equitable, high-quality, clinical care. They support sarcoma, hepatopancreatobiliary cancer and brain/central nervous system cancer patients across the 14 NHS boards in Scotland.

These three MCNs are hosted within the West of Scotland Cancer Network (WoSCAN), and also report to North (NOSCAN) and South East (SCAN) Cancer Networks.

Each managed network has a clinical lead and a manager. Patients, carers, charities, universities, local authorities, external companies and all relevant clinical specialities are also represented.

Regular meetings take place to review progress against agreed objectives, as defined in an annual work plan. The outcomes of these meetings are then reported to the three regional cancer networks.

Any outcomes or service development proposals that have significant potential for service impact are also presented to the three regional planning groups for consideration.

Each MCN is reviewed annually by National Specialist and Screening Services against the service level agreement.

Follow the links below to learn more about each network. Each link will take you to an external website.

Scottish Adult Neuro-Oncology Network (SANON) – linking together health professionals, patients and voluntary sector representatives to ensure the delivery of care for patients with brain and central nervous system tumours.

Scottish HepatoPancreatoBiliary Network (SHPBN) – ensuring equity of care for all patients throughout Scotland with cancer of the liver, pancreas, gallbladder or biliary tree.

Scottish Sarcoma Network (Bone and Soft Tissue Sarcoma) (SSN) – ensuring equity of care for all patients in Scotland with sarcoma.